Home Equities Score What Keeps The Momentum Going in Catabasis Pharmaceuticals Inc. (CATB)?

What Keeps The Momentum Going in Catabasis Pharmaceuticals Inc. (CATB)?

Catabasis Pharmaceuticals Inc. (NASDAQ: CATB) was up 8% in extended hours on Monday thanks to an SEC filing. CATB stock’s year to date performance is 63.55%. A look at its 7-day chart indicates that it has dropped by -3.85% in the last seven days but is up 43.44% in the past month.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.   

The Nasdaq Composite Index ended Monday at new record levels, with the stock market continuing to move higher. There have been major gains in some Nasdaq stocks that have recently been making noise. Tesla and NVIDIA were the stars of the day with big gains. Catabasis Pharmaceuticals Inc. (NASDAQ: CATB) may not be as well known to investors as some of its peers, but the biotech stock has been performing well this year and continues to rise. Here are the things they’re doing to keep the momentum going.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

Perceptive Advisors reportedly filed a 13D filing for Catabasis Pharma (CATB) displaying a new 10.5% stake in the company.

The company’s share price climbed higher a week ago after announcing the acquisition of Quellis Biosciences. Quellis Biosciences’ acquisition by Catabasis Pharma was on a stock-for-stock basis. This consists of it trading all remaining equity interests in the company in exchange for shares of CATB stock and Series X Preferred Stock.

Catabasis Pharma noted that it had started a private investment in public equity at the same time as it acquired Quellis Biosciences. It will be offering new and existing investors shares of a new Series X Preferred Stock. Catabasis Pharma says it will secure an investment of $110 million from the PIPE. Series X Preferred Stock is valued at $3,093.These shares can be converted into 1,000 CATB shares, which would be purchased at a $3.09 price per share.

The company says it will use funds received from the PIPE for studying the potential of QLS-215 in treating hereditary angioedema and obtaining its IND-enabling label. Catabasis Pharma says that this will grant them a total of $150 million in cash proceeds. This will enable them to stay in business until 2023, they say.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.   

Quellis Biosciences is a privately-held biopharmaceutical company founded in 2017. Its focus is on developing new medicines for serious diseases that have been neglected for decades.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Is The OPTT Stock Rising Today?

The shares of leading innovative and cost-effective ocean energy solutions provider Ocean Power Technologies Inc. (OPTT) have been trading up 3.54% in early trades...

IHT Stock Has Been Growing During Premarket Session. What Has Driven That Upward Trend?

At the premarket today, shares of InnSuites Hospitality Trust (NYSE: IHT) rose 10.43% to $2.33. The InnSuites stock gained 3.43% last trading day to finish...

In Premarket Session, Why Is SEAC Stock Rising?

Shares of SeaChange International Inc. (NASDAQ: SEAC) are trading up 11.65% to $1.15 in premarket. SEAC stock gained 1.98% to end Wednesday trading session...

Here is why Qualtrics International Inc (XM) stock surged in the after-hours on Wednesday?

Qualtrics International Inc (XM) stock started the Wednesday, April 21, 2021, in a negative mode and lost 0.059% in normal trading session but in...

ZLAB Stock Is On An Upswing Today. Why?

Today's premarket session has seen shares of Zai Lab Limited (NASDAQ:ZLAB) up 6.12% at $160.00. Last trading session, Zai Lab plunged -8.15% to finish...

IHT Stock Has Been Growing During Premarket Session. What Has Driven That Upward Trend?

At the premarket today, shares of InnSuites Hospitality Trust (NYSE: IHT) rose 10.43% to $2.33. The InnSuites stock gained 3.43% last trading day to finish...

Is There Any Reason Why ACTC Stock Is Rising Before The Market Opens Today?

ArcLight Clean Transition Corp. (NASDAQ: ACTC) shares are trading up 7.12% at $17.90 in premarket trade this morning. ArcLight stock gained 15.64% during the...

BNGO Stock Is On An Upswing Today, Why?

The premarket trading price for Bionano Genomics Inc. (NASDAQ: BNGO) was up 5.75% at $6.25. A share of Bionano stock closed at $5.91 last...

Related News

What Raised The OCGN Stock Higher In After-Hours Session?

In after-market trading hours on Wednesday, Ocugen Inc. (NASDAQ: OCGN) increased 7.85% in value to $7.01. A price range of $5.83 to $6.76 created...

Why did Neubase Therapeutics Inc (NBSE) stock slide in after-hours on Wednesday?

Neubase Therapeutics Inc (NBSE) stock started the day with a 3.09% gain on Wednesday, April 21, 2021, but in the after-hours session, it dropped...

Here is why Teradata Corporation (TDC) stock rallied in the after-market on Wednesday, April 21?

Teradata Corporation (TDC) stock surged 32.90% in the extended trading hours on Wednesday, April 21, 2021. Earlier TDC gained 2.92% in the normal trading...

During After-Hours, What Drove GPM Stock Up More Than 9%?

The shares of Guggenheim Enhanced Equity Income Fund (NYSE: GPM) gained 9.69%, closing at $8.15, in aftermarket trading. In Tuesday's regular session, GPM closed...

Why Sierra Metals Inc (SMTS) stock went up in after-hours on Tuesday April 20?

Sierra Metals Inc (SMTS) stock gained 13.12% in the after-hours session on Tuesday, April 20, 2021, after losing -2.76% to close normal Tuesday's session...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.